{"name":"Spago Nanomedical AB","slug":"spago-nanomedical-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"SN132D","genericName":"SN132D","slug":"sn132d","indication":"Other","status":"phase_2"},{"name":"[177Lu]Lu-SN201","genericName":"[177Lu]Lu-SN201","slug":"177lu-lu-sn201","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"SN132D","genericName":"SN132D","slug":"sn132d","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"[177Lu]Lu-SN201","genericName":"[177Lu]Lu-SN201","slug":"177lu-lu-sn201","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZC0yWVlXTXFjWFhESGlubTE3YTc5RlQzT2xERzg2ODZRN2R2SjRsalF2RGFzdnZ4TEc1V0hySFlTeWdHYTJPNGd1OVFJcF8tUTYtc0lzWTBLNTNrSmdNMkNEVDRoVW4xNElldkVPTFJwUVhhY3ZtSzRlZE1tYTRRSkpnTXlnX19xRW90VnNXSzZxNDQ3bENKbGQwTTQyWE9VMlFjT0RfeFF2dw?oc=5","date":"2026-03-24","type":"pipeline","source":"Yahoo Finance","summary":"Spago Nanomedical's Abstract on Tumorad(R) Accepted for Presentation at Radiopharma Conference - Yahoo Finance","headline":"Spago Nanomedical's Abstract on Tumorad(R) Accepted for Presentation at Radiopharma Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxQMWE1d0ZBY1AzTW9DdVF0YjE5OGl4Q2Zfd0lDY0dHTGdaRjk3X0tCZzBtSGV1NXpHNkRFcER6dnBDZWpuenNzS1VXc2JhTmZDWW9WaVFZNmJ6eVBoN2dpVFFTZFhtdXFHLTllUlRHdUxYNGxreUpLN2s3Z1ljUTBWZVpOVTEwRVBWRXctNUN4a2l6SmNFME5EUnZSRnFjMjRjNlpZMHBTVjhEY3hPNzJPNjFWMDlTTzV4LXh4VlJ6aFlHNElXcXlYcElVQ0U0dEc3VG83UzFpRmtSWk5BZEJKa0NaU1RrczV1NF9LS2c2RnpQSmo0cVRIeUdLS1ZwSTNldU8tYWVneWpFM1hITUdCNkFPR0ZrVXE0SXVfOWdwLWhxb1A2dGNEa2FSXzFPMHU1WUs5TA?oc=5","date":"2026-03-04","type":"pipeline","source":"PR Newswire","summary":"Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight - PR Newswire","headline":"Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFAwWWtHamYxd2FmNlZCaUdlZHFlVW9SaWxpS2kwSUlxb0FOM0pRU2VsOVhmb1dKTnZLZDV0MC12dlFvUzRZMklaRTE2V3JqN29HZTRoRDhnMDQ?oc=5","date":"2020-06-04","type":"pipeline","source":"Yahoo! Finance Canada","summary":"2cureX AB (publ) (2CUREX.ST) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"2cureX AB (publ) (2CUREX.ST) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPNmNEYTFqTG82ZmVsbjU2bGpjWGZra0d2ZFNfRVFVd2NJLWpRYk1DMk9WbVNHNXFoZjVZcUN0ZF9rU1NqUHVGbDRaYkk3SnJldVlNdFJvQko3TWJzUVZfT0VCVXZwUXdITmdsNHNKX2FQbkxJTHhCRmV3ckF1VVV6WjVB?oc=5","date":"2019-12-05","type":"pipeline","source":"Life Science Sweden","summary":"Before you choose a CRO - Life Science Sweden","headline":"Before you choose a CRO","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}